About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Contact the Docs


  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat #8 Overall Rank


« Webinar on Antiviral Patents | Main | CLE on CARES Act »

March 27, 2020


If a sued party has found really good prior art, the first-listed tactic question: “Should patent challengers avoid IPRs on any claims that might be found indefinite?” seems draconian and costly for some types of indefiniteness in view of this and other possible other developments. Leaving only a very costly full trial defense?
“Means-plus-function” claims that are indefinite due to the absence of any specification teaching of any such “means” are a very different form of claim indefiniteness than a claim indefiniteness due to an unresolvable ambiguity in the claim language itself. The former could simply be IPR handled by applying 102 or 103 art against the broadest possible scope of the “means for” statement itself. If the latter type of indefiniteness is limited to only two possibilities the prior art could be required to be asserted against both to be considered.

The comments to this entry are closed.

May 2024

Sun Mon Tue Wed Thu Fri Sat
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31